A detailed history of Tradewinds Capital Management, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 225 shares of SAVA stock, worth $526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Previous 225 -0.0%
Holding current value
$526
Previous $2,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$16.64 - $25.32 $3,744 - $5,697
225 New
225 $3,000
Q2 2022

Jul 21, 2022

SELL
$17.22 - $38.47 $3,874 - $8,655
-225 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$36.77 - $90.91 $8,273 - $20,454
225 New
225 $10,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $93.8M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.